1 outlets · filed 10 November 2026
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
What the coverage shows
All five outlets focus on the FDA’s warning about GLP-1 drugs and a rare eye condition tied to vision loss, and all say the agency is acting on warning labels or patient information. The Guardian US and BBC foreground blindness or vision loss more directly in their headlines, while Ars Technica is alone in stressing that the risk appears small and the data are mixed. CNBC and ABC frame it as a potential increased risk, with ABC naming several drugs and saying the warning is new.
Written by Crossfiled from the 1 headlines and extracts below, not from the articles themselves. It describes how the outlets framed this, not what happened. Open any headline for a summary of that article.
How it broke
Get the 5 stories every outlet is covering, every morning. Free.
One email a day. Unsubscribe in one click. We host no journalism and never sell your address.
More on Health
- Indonesia factory fire kills three, 36 missing 3 outlets
- Princess of Wales opens up about cancer 2 outlets
- Princess Kate reflects on healing in new documentary: "Cancer does change you" 2 outlets
- Violence breaks out in Mexico after capture of drug kingpin wanted by FBI 2 outlets
